EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Ibuprofen in the Management of Viral Infections: The Lesson of COVID‐19 for Its Use in a Clinical Setting

Gianmarco Marcianò, Lucia Muraca iD, Vincenzo Rania, Luca Gallelli

The Journal of Clinical Pharmacology · 2023

DOI: 10.1002/jcph.2258 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Clinical Pharmacology, 2023. Verfasst von Gianmarco Marcianò und 3 weiteren Autor:innen. Beteiligte Einrichtung: Operative Unit of Pharmacology and Pharmacovigilance, "Mater Domini" Hospital, Department of Health Science, University Magna Graecia, Catanzaro, Ita…. Hauptthemen laut MEDLINE: Ibuprofen, COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonsteroidal anti‐inflammatory drugs (NSAIDs) are commonly used for the management of fever, pain, and inflammation. However, they have always been considered to have a double‐faced role, according to their capacity to manage inflammation but also their possible reduction of immune system response and diagnosis delay. This last point could favor a dramatic increase of viral infection diffusion, possibly leading to a more severe outcome. The advent of severe acute respiratory syndrome coronavirus 2 excluded the use of NSAIDs, particularly ibuprofen, and then indicated this drug as the better NSAID to manage infected outpatients and prevent complications. Several authors described the role of NSAIDs and ibuprofen in preventing cytokine storm and modulating the immune system. However, the development of both adverse drug reactions (i.e., gastrointestinal, renal, hepatic, and cardiovascular) and drug interaction recalled the necessity of prescribing the better NSAID for each patient. In this narrative review, we describe the role of NSAIDs, particularly of ibuprofen, in the management of viral symptoms, suggesting that the NSAID may be chosen considering the characteristics of the patient, the comorbidity, and the polytherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IbuprofenCOVID-19HumansAnti-Inflammatory Agents, Non-SteroidalPainInflammation

Stichwörter der Autor:innen

NSAIDsefficacymechanism of actionpolytherapysafetyviral infections

Substanzen

IbuprofenAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Operative Unit of Pharmacology and Pharmacovigilance, "Mater Domini" Hospital, Department of Health Science, University Magna Graecia, Catanzaro, Italy.
  • Department of Primary Care, Catanzaro, Italy.
  • Research Center FAS@UMG, Department of Health Science, University Magna Graecia, Catanzaro, Italy.

ORCID-Profile: Lucia Muraca

Zitieren

APA

Marcianò, G., Muraca, L., Rania, V., & Gallelli, L. (2023). Ibuprofen in the Management of Viral Infections: The Lesson of COVID‐19 for Its Use in a Clinical Setting. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2258

Vancouver

Marcianò G, Muraca L, Rania V, Gallelli L. Ibuprofen in the Management of Viral Infections: The Lesson of COVID‐19 for Its Use in a Clinical Setting. The Journal of Clinical Pharmacology. 2023. doi:10.1002/jcph.2258

BibTeX
@article{Marcian2023,
  author = {Marcianò, Gianmarco and Muraca, Lucia and Rania, Vincenzo and Gallelli, Luca},
  title = {Ibuprofen in the Management of Viral Infections: The Lesson of COVID‐19 for Its Use in a Clinical Setting},
  journal = {The Journal of Clinical Pharmacology},
  year = {2023},
  doi = {10.1002/jcph.2258}
}
Kostenlos starten →